4/23
05:00 pm
atr
Aptar Declares Quarterly Dividend
Low
Report
Aptar Declares Quarterly Dividend
4/22
05:13 pm
atr
Aptar Recognized as One of America's Climate Leaders by USA Today for the Fourth Consecutive Year [Yahoo! Finance]
Low
Report
Aptar Recognized as One of America's Climate Leaders by USA Today for the Fourth Consecutive Year [Yahoo! Finance]
4/22
05:00 pm
atr
Aptar Recognized as One of America’s Climate Leaders by USA Today for the Fourth Consecutive Year
Low
Report
Aptar Recognized as One of America’s Climate Leaders by USA Today for the Fourth Consecutive Year
4/8
05:00 pm
atr
Aptar Digital Health Partners with Enable Injections for enFuse® Companion Digital Solution
Low
Report
Aptar Digital Health Partners with Enable Injections for enFuse® Companion Digital Solution
4/8
04:00 pm
atr
Aptar Digital Health Partners with Enable Injections for enFuse® Companion Digital Solution
Low
Report
Aptar Digital Health Partners with Enable Injections for enFuse® Companion Digital Solution
3/30
06:18 am
atr
AptarGroup (ATR) had its "hold (c)" rating reaffirmed by
Weiss Ratings.
Low
Report
AptarGroup (ATR) had its "hold (c)" rating reaffirmed by
Weiss Ratings.
3/26
11:10 pm
atr
???????????????????????(CAGR)8%????????2035????202?1,000??????????? [CNET News]
Low
Report
???????????????????????(CAGR)8%????????2035????202?1,000??????????? [CNET News]
3/20
08:44 am
atr
AptarGroup (ATR) was upgraded by Wells Fargo & Company from "equal weight" to "overweight". They now have a $144.00 price target on the stock.
Low
Report
AptarGroup (ATR) was upgraded by Wells Fargo & Company from "equal weight" to "overweight". They now have a $144.00 price target on the stock.
3/19
05:32 pm
atr
Aptar's Unidose Powder Nasal Delivery System Used in ENA Respiratory Phase II Clinical Study of Investigational INNA-051 Nasal Spray [Yahoo! Finance]
Low
Report
Aptar's Unidose Powder Nasal Delivery System Used in ENA Respiratory Phase II Clinical Study of Investigational INNA-051 Nasal Spray [Yahoo! Finance]
3/19
05:00 pm
atr
Aptar’s Unidose Powder Nasal Delivery System Used in ENA Respiratory Phase II Clinical Study of Investigational INNA-051 Nasal Spray
Low
Report
Aptar’s Unidose Powder Nasal Delivery System Used in ENA Respiratory Phase II Clinical Study of Investigational INNA-051 Nasal Spray
3/18
08:01 am
atr
New Strong Sell Stocks for March 18th [Yahoo! Finance]
Medium
Report
New Strong Sell Stocks for March 18th [Yahoo! Finance]
3/17
05:34 pm
atr
Aptar Announces Gael Touya as its Next Chief Executive Officer; Stephan B. Tanda to Retire by the End of the Year [Yahoo! Finance]
Medium
Report
Aptar Announces Gael Touya as its Next Chief Executive Officer; Stephan B. Tanda to Retire by the End of the Year [Yahoo! Finance]
3/17
05:00 pm
atr
Aptar Announces Gael Touya as its Next Chief Executive Officer; Stephan B. Tanda to Retire by the End of the Year
Medium
Report
Aptar Announces Gael Touya as its Next Chief Executive Officer; Stephan B. Tanda to Retire by the End of the Year
3/16
09:23 pm
atr
A Fresh Look At AptarGroup (ATR) Valuation After Recent Share Price Weakness [Yahoo! Finance]
Low
Report
A Fresh Look At AptarGroup (ATR) Valuation After Recent Share Price Weakness [Yahoo! Finance]
3/16
05:20 pm
atr
Aptar's Intranasal Delivery System Used in Phase II Clinical Study for Investigational SPONTAN® Nasal Spray [Yahoo! Finance]
Low
Report
Aptar's Intranasal Delivery System Used in Phase II Clinical Study for Investigational SPONTAN® Nasal Spray [Yahoo! Finance]
3/16
05:00 pm
atr
Aptar’s Intranasal Delivery System Used in Phase II Clinical Study for Investigational SPONTAN® Nasal Spray
Low
Report
Aptar’s Intranasal Delivery System Used in Phase II Clinical Study for Investigational SPONTAN® Nasal Spray
3/9
04:29 pm
atr
New Strong Sell Stocks for March 9th [Yahoo! Finance Canada]
Low
Report
New Strong Sell Stocks for March 9th [Yahoo! Finance Canada]
2/19
07:03 am
atr
Pharmaceutical Packaging Market Trends and Growth Projections to 2030 Featuring Profiles of AptarGroup, Amcor, SGD Pharma, West Pharmaceutical Services, SCHOTT Pharma and Other Key Players [Yahoo! Finance]
Low
Report
Pharmaceutical Packaging Market Trends and Growth Projections to 2030 Featuring Profiles of AptarGroup, Amcor, SGD Pharma, West Pharmaceutical Services, SCHOTT Pharma and Other Key Players [Yahoo! Finance]
2/18
05:00 pm
atr
Aptar to Participate in Upcoming Investor Conferences
Low
Report
Aptar to Participate in Upcoming Investor Conferences
2/10
06:28 am
atr
AptarGroup, Inc.'s (NYSE:ATR) Intrinsic Value Is Potentially 58% Above Its Share Price [Yahoo! Finance]
Low
Report
AptarGroup, Inc.'s (NYSE:ATR) Intrinsic Value Is Potentially 58% Above Its Share Price [Yahoo! Finance]
2/9
11:51 pm
atr
A Look At AptarGroup (ATR) Valuation As Earnings Guidance And New US$600 Million Buyback Draw Interest [Yahoo! Finance]
Low
Report
A Look At AptarGroup (ATR) Valuation As Earnings Guidance And New US$600 Million Buyback Draw Interest [Yahoo! Finance]
2/9
10:05 am
atr
AptarGroup (NYSE:ATR) was given a new $156.00 price target on by analysts at Robert W. Baird.
Low
Report
AptarGroup (NYSE:ATR) was given a new $156.00 price target on by analysts at Robert W. Baird.
2/6
05:56 pm
atr
AptarGroup Q4 Earnings Call Highlights [Yahoo! Finance]
Medium
Report
AptarGroup Q4 Earnings Call Highlights [Yahoo! Finance]
2/6
04:17 pm
atr
AptarGroup Inc (ATR) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Margin ... [Yahoo! Finance]
Medium
Report
AptarGroup Inc (ATR) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Margin ... [Yahoo! Finance]
2/6
03:50 pm
atr
AptarGroup outlines 2026 margin improvement and targets 7%–11% long-term pharma core sales growth amid emergency medicine headwinds [Seeking Alpha]
Low
Report
AptarGroup outlines 2026 margin improvement and targets 7%–11% long-term pharma core sales growth amid emergency medicine headwinds [Seeking Alpha]